The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes
Recruiting now
Conditions studied: Diabetes Mellitus
In brief
Exhaled volatile organic compounds will be measured during daytime with the goal to identifying circadian variability. The study incudes three subgroups: people without diabetes, people with type 1 diabetes, and people with type 2 diabetes. A total of 60 people will be recruited for the study.
Key facts
- Study ID
- NCT05984979
- Run by
- University of Bern
- People needed
- 60
- Starts
- 2023-08-07
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-12-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subgroup 1:
- Age 18 or older
- HbA1c below 6.5%
- Written informed consent
- Subgroup 2:
- Age 18 or older
- T1D (Type 1 diabetes) with MDI (multiple daily injection) or CSII (Continuous subcutaneous insulin infusion therapy) therapy >1 year
- Written informed consent
- Subgroup 3
- Age 18 or older
- T2D (Type 2 diabetes) with oral antidiabetic medication or insulin therapy
- Written informed consent
You may not qualify if…
- Pregnancy or breastfeeding
- Smoking (last cigarette less than 6 months ago)
- Any chronical lung and intestinal disease diagnosis (such as intestinal bowel disease (IBD); asthma; COPD (chronic obstructive pulmonary disease); lung cancer, …)
- Coeliac disease
- Lactose and fructose intolerance
- Any acute disease diagnosis (such as viral or bacterial infection)
- Drinking habit of more than four units of alcohol per day
- Current inhaled medicines treatments
- Antibiotic treatment in the previous 4 months
Where it is running
- University of Bern — Bern, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.